{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:03:42Z","timestamp":1790892222985,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02404-x","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T01:24:12Z","timestamp":1744680252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of dexamethasone versus intravitreal aflibercept implants for macular edema: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9920-7075","authenticated-orcid":false,"given":"Khaled","family":"Moghib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Shivashankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Abunamoos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al Hasan","family":"Mia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-560X","authenticated-orcid":false,"given":"Izere","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoria","family":"Ghanm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Aldemerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona I.","family":"Elshamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"8","key":"2404_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/eye.2011.92","volume":"25","author":"M Laouri","year":"2011","unstructured":"Laouri M, Chen E, Looman M, Gallagher M. The burden of disease of retinal vein occlusion: a review of the literature. Eye. 2011;25(8):981\u20138.","journal-title":"Eye"},{"issue":"1","key":"2404_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12886-018-0779-1","volume":"18","author":"Y He","year":"2018","unstructured":"He Y, Ren X-J, Hu B-J, Lam W-C, Li X-R. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema. BMC Ophthalmol. 2018;18(1):121.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"2404_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","volume":"117","author":"S Rogers","year":"2010","unstructured":"Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117(2):313-9.e1.","journal-title":"Ophthalmology"},{"issue":"11","key":"2404_CR4","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580\u201391.","journal-title":"Ophthalmology"},{"issue":"9","key":"2404_CR5","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.18240\/ijo.2022.09.15","volume":"15","author":"X-Y Qiu","year":"2022","unstructured":"Qiu X-Y, Hu X-F, Qin Y-Z, Ma J-X, Liu Q-P, Qin L, et al. Comparison of intravitreal aflibercept and dexamethasone implant in the treatment of macular edema associated with diabetic retinopathy or retinal vein occlusion: a Meta-analysis and systematic review. Int J Ophthalmol. 2022;15(9):1511\u20139.","journal-title":"Int J Ophthalmol"},{"key":"2404_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.12688\/f1000research.19198.1","volume":"8","author":"R Sacconi","year":"2019","unstructured":"Sacconi R, Giuffr\u00e8 C, Corbelli E, Borrelli E, Querques G, Bandello F. Emerging therapies in the management of macular edema: a review. [version 1; peer review: 2 approved]. F1000Res. 2019;8:1413.","journal-title":"F1000Res"},{"issue":"12","key":"2404_CR7","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2337\/diabetes.47.12.1953","volume":"47","author":"DA Antonetti","year":"1998","unstructured":"Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes. 1998;47(12):1953\u20139.","journal-title":"Diabetes"},{"issue":"4","key":"2404_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/IAE.0000000000001210","volume":"37","author":"RJ Hillier","year":"2017","unstructured":"Hillier RJ, Ojaimi E, Wong DT, Mak MYK, Berger AR, Kohly RP, et al. Aqueous humor cytokine levels as biomarkers of disease severity in diabetic macular edema. Retina (Philadelphia, Pa). 2017;37(4):761\u20139.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"2","key":"2404_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000502042","volume":"243","author":"E S\u0131rakaya","year":"2020","unstructured":"S\u0131rakaya E, K\u00fc\u00e7\u00fck B, A\u011faday\u0131 A. Aflibercept treatment for macular edema following branch retinal vein occlusion: age-based responses. Ophthalmologica. 2020;243(2):94\u2013101.","journal-title":"Ophthalmologica"},{"issue":"12","key":"2404_CR10","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1517\/14712598.2015.1086744","volume":"15","author":"I Chatziralli","year":"2015","unstructured":"Chatziralli I, Nicholson L, Sivaprasad S, Hykin P. Intravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials. Expert Opin Biol Ther. 2015;15(12):1685\u201397.","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"2404_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21037\/aoj-23-55","volume":"15","author":"CP Olson","year":"2024","unstructured":"Olson CP, Kennedy MI, DePhillipo NN, Tagliero AJ, LaPrade RF, Kennedy NI. Effect of anti-inflammatory treatments on patient outcomes and concentrations of inflammatory modulators in the post-surgical and post-traumatic tibiofemoral joint setting: a narrative review. Ann Joint. 2024;15(9):9.","journal-title":"Ann Joint"},{"issue":"2","key":"2404_CR12","first-page":"478","volume":"36","author":"AF Clark","year":"1995","unstructured":"Clark AF, Wilson K, de Kater AW, Allingham RR, McCartney MD. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci. 1995;36(2):478\u201389.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2404_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/1120672120930603","volume":"31","author":"A Comet","year":"2021","unstructured":"Comet A, Gascon P, Ramtohul P, Donnadieu B, Denis D, Matonti F. INVICTUS: Intravitreal anti-VEGF and dexamethasone implant comparison for the treatment of diabetic macular edema: a 12 months follow-up study. Eur J Ophthalmol. 2021;31(2):754\u20138.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"2404_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/IAE.0000000000002196","volume":"39","author":"M Iglicki","year":"2019","unstructured":"Iglicki M, Busch C, Zur D, Okada M, Mariussi M, Chhablani JK, et al. dexamethasone implant for diabetic macular edema in naive compared with refractory eyes: The International Retina Group real-life 24-month multicenter study. The IRGREL-DEX study. Retina (Philadelphia, Pa). 2019;39(1):44\u201351.","journal-title":"Retina (Philadelphia, Pa)."},{"issue":"6","key":"2404_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00592-018-1117-z","volume":"55","author":"M Iglicki","year":"2018","unstructured":"Iglicki M, Zur D, Busch C, Okada M, Loewenstein A. Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the \u201cDR-Pro-DEX Study.\u201d Acta Diabetol. 2018;55(6):541\u20137.","journal-title":"Acta Diabetol"},{"issue":"1","key":"2404_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range, and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"2404_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00592-019-01357-y","volume":"56","author":"M Iglicki","year":"2019","unstructured":"Iglicki M, Zur D, Fung A, Gabrielle P-H, Lupidi M, Santos R, et al. TRActional DIabetic retinal detachment surgery with co-adjuvant intravitreal dexamethasone implant: the TRADITION STUDY. Acta Diabetol. 2019;56(10):1141\u20137.","journal-title":"Acta Diabetol"},{"issue":"2","key":"2404_CR18","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1111\/aos.14230","volume":"98","author":"D Zur","year":"2020","unstructured":"Zur D, Iglicki M, Sala-Puigdollers A, Chhablani J, Lupidi M, Fraser-Bell S, et al. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular edema treated with dexamethasone implant. Acta Ophthalmol. 2020;98(2):e217\u201323.","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"2404_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00592-020-01530-8","volume":"57","author":"M Iglicki","year":"2020","unstructured":"Iglicki M, Zur D, Negri HP, Esteves J, Arias R, Holsman E, et al. Results in comparison between 30 gauge ultrathin wall and 27 gauge needle in sutureless intraocular lens flanged technique in diabetic patients: 24-month follow-up study. Acta Diabetol. 2020;57(10):1151\u20137.","journal-title":"Acta Diabetol"},{"issue":"2","key":"2404_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41433-021-01722-8","volume":"36","author":"M Iglicki","year":"2022","unstructured":"Iglicki M, Gonz\u00e1lez DP, Loewenstein A, Zur D. Next-generation anti-VEGF agents for diabetic macular edema. Eye. 2022;36(2):273\u20137.","journal-title":"Eye"},{"issue":"4","key":"2404_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/s41433-020-01309-9","volume":"35","author":"M Iglicki","year":"2021","unstructured":"Iglicki M, Gonz\u00e1lez DP, Loewenstein A, Zur D. Longer-acting treatments for neovascular age-related macular degeneration-present and future. Eye. 2021;35(4):1111\u20136.","journal-title":"Eye"},{"issue":"2","key":"2404_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ophtha.2017.08.031","volume":"125","author":"D Zur","year":"2018","unstructured":"Zur D, Iglicki M, Busch C, Invernizzi A, Mariussi M, Loewenstein A, et al. OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant. Ophthalmology. 2018;125(2):267\u201375.","journal-title":"Ophthalmology"},{"issue":"2","key":"2404_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41433-022-01931-9","volume":"37","author":"M Iglicki","year":"2023","unstructured":"Iglicki M, Busch C, Lanzetta P, Sarao V, Veritti D, Rassu N, et al. Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? The VITDEX study. Eye. 2023;37(2):280\u20134.","journal-title":"Eye"},{"issue":"11","key":"2404_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.oret.2021.01.013","volume":"5","author":"F Tang","year":"2021","unstructured":"Tang F, Luenam P, Ran AR, Quadeer AA, Raman R, Sen P, et al. Detection of diabetic retinopathy from ultra-widefield scanning laser ophthalmoscope images: a multicenter deep learning analysis. Ophthalmol Retina. 2021;5(11):1097\u2013106.","journal-title":"Ophthalmol Retina"},{"key":"2404_CR25","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training [Internet]. https:\/\/training.cochrane.org\/handbook\/current. Accessed 17 Aug 2024."},{"key":"2404_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"M Page","year":"2021","unstructured":"Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"issue":"13","key":"2404_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193\u2013203.","journal-title":"N Engl J Med"},{"issue":"1","key":"2404_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"issue":"366","key":"2404_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. Rob 2: a revised tool for assessing the risk of bias in randomized trials. BMJ. 2019;28(366): l4898.","journal-title":"BMJ"},{"issue":"1","key":"2404_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55\u201361.","journal-title":"Res Synth Methods"},{"issue":"9","key":"2404_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"7109","key":"2404_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"key":"2404_CR33","doi-asserted-by":"crossref","unstructured":"Kanters S. Fixed- and random-effects models. Methods Mol Biol. 2022;2345:41\u201365.","DOI":"10.1007\/978-1-0716-1566-9_3"},{"issue":"1","key":"2404_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"issue":"7521","key":"2404_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/bmj.331.7521.903","volume":"331","author":"DG Altman","year":"2005","unstructured":"Altman DG, Bland JM. Standard deviations and standard errors. BMJ. 2005;331(7521):903.","journal-title":"BMJ"},{"key":"2404_CR36","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.3\u00a0(updated February\u00a02022). Cochrane, 2022 [Internet]. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor. https:\/\/training.cochrane.org\/handbook. Accessed 7 May 2023."},{"issue":"3","key":"2404_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1037\/0033-2909.99.3.400","volume":"99","author":"R Rosenthal","year":"1986","unstructured":"Rosenthal R, Rubin DB. Meta-analytic procedures for combining studies with multiple effect sizes. Psychol Bull. 1986;99(3):400\u20136.","journal-title":"Psychol Bull"},{"key":"2404_CR38","doi-asserted-by":"crossref","unstructured":"Bergh D. Sample Size and Chi-Squared Test of Fit\u2014A Comparison Between a Random Sample Approach and a Chi-Square Value Adjustment Method Using Swedish Adolescent Data. In: Zhang Q, Yang H, editors. Pacific Rim Objective Measurement Symposium (PROMS) 2014 conference proceedings. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015. p. 197\u2013211.","DOI":"10.1007\/978-3-662-47490-7_15"},{"issue":"Suppl 3","key":"2404_CR39","doi-asserted-by":"publisher","first-page":"S453","DOI":"10.4103\/IJO.IJO_2310_23","volume":"72","author":"O Parca","year":"2024","unstructured":"Parca O, Cetin EN. Comparison of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema: a 12-month real-life experience. Indian J Ophthalmol. 2024;72(Suppl 3):S453\u20138.","journal-title":"Indian J Ophthalmol"},{"issue":"1\u20132","key":"2404_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000473864","volume":"238","author":"J Hanhart","year":"2017","unstructured":"Hanhart J, Rozenman Y. Comparison of intravitreal ranibizumab, aflibercept, and dexamethasone implant after bevacizumab failure in macular edema secondary to retinal vascular occlusions. Ophthalmologica. 2017;238(1\u20132):110\u20138.","journal-title":"Ophthalmologica"},{"issue":"4","key":"2404_CR41","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s10792-017-0618-z","volume":"38","author":"HE Kald\u0131r\u0131m","year":"2018","unstructured":"Kald\u0131r\u0131m HE, Yazgan S. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Int Ophthalmol. 2018;38(4):1549\u201358.","journal-title":"Int Ophthalmol"},{"issue":"6","key":"2404_CR42","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/IAE.0000000000002537","volume":"40","author":"C Ozsaygili","year":"2020","unstructured":"Ozsaygili C, Duru N. Comparison of intravitreal dexamethasone implant and aflibercept in patients with treatment-naive diabetic macular edema with serous retinal detachment. Retina (Philadelphia, Pa). 2020;40(6):1044\u201352.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"4","key":"2404_CR43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10792-018-0890-6","volume":"39","author":"OE Yucel","year":"2019","unstructured":"Yucel OE, Birinci H, Sullu Y. The short-term efficacy of intravitreal ranibizumab, aflibercept, and dexamethasone implant in the treatment of macular edema due to non-ischemic central retinal vein occlusion. Int Ophthalmol. 2019;39(4):891\u2013901.","journal-title":"Int Ophthalmol"},{"issue":"7","key":"2404_CR44","first-page":"1001","volume":"72","author":"D Chakraborty","year":"2024","unstructured":"Chakraborty D, Mondal S, Sengupta S, Maiti A, Boral S, Das A, et al. Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a qazi-randomized study in India. Indian J Ophthalmol. 2024;72(7):1001\u20136.","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"2404_CR45","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1089\/jop.2020.0004","volume":"36","author":"M Aksoy","year":"2020","unstructured":"Aksoy M, Yilmaz G, Vardarli I, Akkoyun I. Choroidal thickness after dexamethasone implant or aflibercept in patients with diabetic macular edema persistent to ranibizumab. J Ocul Pharmacol Ther. 2020;36(8):629\u201335.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"2404_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/15569527.2019.1657884","volume":"38","author":"S Bolukbasi","year":"2019","unstructured":"Bolukbasi S, Cakir A, Erden B, Karaca G. Comparison of the short-term effect of aflibercept and dexamethasone implant on serous retinal detachment in the treatment of naive diabetic macular edema. Cutan Ocul Toxicol. 2019;38(4):401\u20135.","journal-title":"Cutan Ocul Toxicol"},{"key":"2404_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.phrs.2015.05.013","volume":"99","author":"T Behl","year":"2015","unstructured":"Behl T, Kotwani A. Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy. Pharmacol Res. 2015;99:137\u201348.","journal-title":"Pharmacol Res"},{"issue":"2","key":"2404_CR48","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/ijo.IJO_459_20","volume":"69","author":"A Salimi","year":"2021","unstructured":"Salimi A, Vila N, Modabber M, Kapusta M. One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders. Indian J Ophthalmol. 2021;69(2):360\u20137.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"2404_CR49","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","volume":"122","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA, Clark WL, Boyer DS, Heier JS, Brown DM, Vitti R, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology. 2015;122(3):538\u201344.","journal-title":"Ophthalmology"},{"issue":"8","key":"2404_CR50","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.4239\/wjd.v12.i8.1220","volume":"12","author":"O Karti","year":"2021","unstructured":"Karti O, Saatci AO. Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema. World J Diabetes. 2021;12(8):1220\u201332.","journal-title":"World J Diabetes"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02404-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:54:15Z","timestamp":1744728855000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02404-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2404"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02404-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}